Id |
Subject |
Object |
Predicate |
Lexical cue |
T205 |
8-10 |
IN |
denotes |
in |
T206 |
11-19 |
NN |
denotes |
COVID-19 |
T207 |
20-30 |
VBD |
denotes |
correlated |
T208 |
31-35 |
IN |
denotes |
with |
T209 |
36-44 |
NN |
denotes |
severity |
T210 |
44-45 |
-COMMA- |
denotes |
, |
T211 |
46-57 |
NN |
denotes |
criticality |
T212 |
57-58 |
-COMMA- |
denotes |
, |
T213 |
59-64 |
JJ |
denotes |
viral |
T214 |
65-69 |
NN |
denotes |
load |
T215 |
69-70 |
-COMMA- |
denotes |
, |
T216 |
71-74 |
CC |
denotes |
and |
T217 |
75-84 |
NN |
denotes |
prognosis |
T218 |
85-87 |
IN |
denotes |
of |
T219 |
88-96 |
NNS |
denotes |
patients |
T220 |
97-101 |
IN |
denotes |
with |
T221 |
102-110 |
NN |
denotes |
COVID-19 |
T222 |
112-123 |
NNP |
denotes |
Tocilizumab |
T223 |
123-124 |
-COMMA- |
denotes |
, |
T224 |
125-126 |
DT |
denotes |
a |
T225 |
127-137 |
JJ |
denotes |
monoclonal |
T226 |
138-146 |
NN |
denotes |
antibody |
T227 |
147-154 |
IN |
denotes |
against |
T228 |
155-158 |
NN |
denotes |
IL6 |
T229 |
158-159 |
-COMMA- |
denotes |
, |
T230 |
160-165 |
MD |
denotes |
could |
T231 |
166-172 |
VB |
denotes |
confer |
T232 |
173-181 |
JJ |
denotes |
clinical |
T233 |
182-189 |
NN |
denotes |
benefit |
T234 |
190-192 |
IN |
denotes |
in |
T235 |
193-201 |
NNS |
denotes |
patients |
R197 |
T216 |
T205 |
arg2Of |
and,in |
R198 |
T206 |
T207 |
arg2Of |
COVID-19,correlated |
R199 |
T207 |
T208 |
arg1Of |
correlated,with |
R200 |
T209 |
T208 |
arg2Of |
severity,with |
R201 |
T209 |
T210 |
arg1Of |
severity,"," |
R202 |
T211 |
T210 |
arg2Of |
criticality,"," |
R203 |
T206 |
T212 |
arg1Of |
COVID-19,"," |
R204 |
T214 |
T212 |
arg2Of |
load,"," |
R205 |
T214 |
T213 |
arg1Of |
load,viral |
R206 |
T216 |
T215 |
arg1Of |
and,"," |
R207 |
T212 |
T216 |
arg1Of |
",",and |
R208 |
T217 |
T216 |
arg2Of |
prognosis,and |
R209 |
T217 |
T218 |
arg1Of |
prognosis,of |
R210 |
T219 |
T218 |
arg2Of |
patients,of |
R211 |
T219 |
T220 |
arg1Of |
patients,with |
R212 |
T221 |
T220 |
arg2Of |
COVID-19,with |
R213 |
T222 |
T223 |
arg1Of |
Tocilizumab,"," |
R214 |
T226 |
T223 |
arg2Of |
antibody,"," |
R215 |
T226 |
T224 |
arg1Of |
antibody,a |
R216 |
T226 |
T225 |
arg1Of |
antibody,monoclonal |
R217 |
T226 |
T227 |
arg1Of |
antibody,against |
R218 |
T228 |
T227 |
arg2Of |
IL6,against |
R219 |
T231 |
T229 |
arg1Of |
confer,"," |
R220 |
T222 |
T230 |
arg1Of |
Tocilizumab,could |
R221 |
T231 |
T230 |
arg2Of |
confer,could |
R222 |
T222 |
T231 |
arg1Of |
Tocilizumab,confer |
R223 |
T233 |
T231 |
arg2Of |
benefit,confer |
R224 |
T233 |
T232 |
arg1Of |
benefit,clinical |
R225 |
T231 |
T234 |
arg1Of |
confer,in |
R226 |
T235 |
T234 |
arg2Of |
patients,in |